Friday, February 3, 2012

Cancer Research Now: The DES Story, Lessons Learned

Dr. Robert Hoover, director of NCI's Epidemiology and Biostatistics Program, discusses a new study of diethylstilbestrol (DES), a drug once prescribed to pregnant women. Dr. Hoover describes the history behind DES and the long-term health effects that are now known to be associated with prenatal exposure to the drug.

Post a Comment

Popular Posts Last Week

Popular Posts This Month

Popular Posts All Time